NCT00005041View on ClinicalTrials.gov

R115777 in Treating Patients With Relapsed Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1999

Primary Completion Date

May 31, 2000

Conditions
Lung Cancer
Interventions
DRUG

tipifarnib

Trial Locations (1)

10016

Kaplan Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00005041 - R115777 in Treating Patients With Relapsed Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter